We use cookies on this site to enable your digital experience. By continuing to use this site, you are agreeing to our cookie policy. close

July 26, 2013

United States of America et al v. Aegerion Pharmaceuticals, Inc.

View recent docket activity


Reflects complaints, answers, motions, orders and trial notes entered from Jan. 1, 2011.
Additional or older documents may be available in Pacer.


Coverage

  1. June 19, 2018

    Former Aegerion Execs Say FDA Approval Negates FCA Case

    Former executives at Aegerion Pharmaceuticals Inc. argued Tuesday that a False Claims Act case against them ignores a federal regulatory program that gave marketers and doctors explicit permission to recommend an expensive cholesterol drug to people who did not have the rare genetic disorder it was created for.

2 other articles on this case. View all »

Parties

To view the parties, register now.